Pharma Giant Flirts With Record High As Copycat Drugs Gain Steam [Investor's Business Daily]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Investors Business Daily
Related news 7/17/2019 Roche shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails Trump Kills Drug Rebate Proposal — And Pharmaceutical Stocks Tumble Pfizer Stock Is The Biggest Pharma — But Should You Buy It? How This Novartis Mashup Could Validate A Biotech Company's Cancer Drug EpiPen Shortage Leaves Patients Scrambling Just To Stay Alive Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019 Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump Why Biopharmas Are Betting On $2 Million Cures — And Big Pharma Might Join Novartis stock flirted with a record high Thursday after the pharmaceutical company topped second-quarter expectations and raised its 2019 guidance. In morning action on the stock market today , shares of Novartis ( NVS ) jumped 4.1%, near 94. Novartis stock is now mor
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Why Amgen (AMGN) Outpaced the Stock Market Today [Yahoo! Finance]Yahoo! Finance
- 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at UBS Group AG from $314.00 to $284.00. They now have a "neutral" rating on the stock.MarketBeat
- Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.MarketBeat
AMGN
Earnings
- 2/6/24 - Beat
AMGN
Sec Filings
- 4/17/24 - Form DEFA14A
- 4/17/24 - Form DEF
- 4/10/24 - Form ARS
- AMGN's page on the SEC website